The human immunodeficiency virus type 1 Rev protein: a pivotal protein in the viral life cycle.

[1]  O. Bagasra,et al.  Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Jeang,et al.  A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Dombrowicz,et al.  Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene , 1993, Cell.

[4]  J. Hauber,et al.  Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans- activation , 1993, The Journal of cell biology.

[5]  D. Kolson,et al.  Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. , 1993, Virology.

[6]  M. Malim,et al.  Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes , 1993, Molecular and cellular biology.

[7]  S. Zigmond,et al.  Focusing on unpolymerized actin , 1993, The Journal of cell biology.

[8]  Michael R. Green,et al.  Small molecules that selectively block RNA binding of HIV-1 rev protein inhibit rev function and viral production , 1993, Cell.

[9]  J. Kjems,et al.  The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly , 1993, Journal of virology.

[10]  B. Cullen,et al.  Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus , 1993, Journal of virology.

[11]  Derek Hudson,et al.  RNA recognition by an isolated α helix , 1993, Cell.

[12]  W. Greene,et al.  Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo , 1993, Journal of virology.

[13]  D. Trono,et al.  The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent , 1993, Journal of virology.

[14]  A. Frankel,et al.  Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Pavlakis,et al.  Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression , 1992, Journal of virology.

[16]  H. Park,et al.  Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA , 1992, Journal of virology.

[17]  D. McDonald,et al.  Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site , 1992, Journal of virology.

[18]  O. Bagasra,et al.  Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Hope,et al.  trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes , 1992, Journal of virology.

[20]  G. Pavlakis,et al.  The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs , 1992, Molecular and cellular biology.

[21]  P. Sharp,et al.  Specific binding of a basic peptide from HIV‐1 Rev. , 1992, The EMBO journal.

[22]  D. Trono,et al.  Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency , 1992, Journal of virology.

[23]  G. Pavlakis,et al.  Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein , 1992, Journal of virology.

[24]  Michael R. Green,et al.  HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA , 1991, Cell.

[25]  D. McDonald,et al.  Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif , 1991, Journal of virology.

[26]  P. Sharp,et al.  Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev , 1991, Cell.

[27]  A. Skalka,et al.  Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression , 1991, Journal of virology.

[28]  T. Hope,et al.  Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Karn,et al.  Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Malim,et al.  Mutational definition of the human immunodeficiency virus type 1 Rev activation domain , 1991, Journal of virology.

[31]  B Tidor,et al.  Arginine-mediated RNA recognition: the arginine fork , 1991, Science.

[32]  C. Stoltzfus,et al.  Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing , 1991, Journal of virology.

[33]  I. Chen,et al.  Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. , 1991, Genes & development.

[34]  M. Malim,et al.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency , 1991, Cell.

[35]  D. McDonald,et al.  Minimal Rev-response element for type 1 human immunodeficiency virus , 1991, Journal of virology.

[36]  B. Cullen,et al.  Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products , 1991, Journal of virology.

[37]  B. Cullen,et al.  Human immunodeficiency virus as a prototypic complex retrovirus , 1991, Journal of virology.

[38]  M. Rosenberg,et al.  Rev-dependent expression of human immunodeficiency virus type 1 gp160 in Drosophila melanogaster cells , 1990, Molecular and cellular biology.

[39]  D. Baltimore,et al.  A human cell factor is essential for HIV‐1 Rev action. , 1990, The EMBO journal.

[40]  E. Fenyö,et al.  Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs , 1990, Journal of virology.

[41]  D. McDonald,et al.  Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus , 1990, Journal of virology.

[42]  E. Reddy,et al.  Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Hammarskjöld,et al.  U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. McDonald,et al.  Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Antelman,et al.  Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Turek,et al.  Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells , 1990, Journal of virology.

[47]  D. Chang,et al.  Messenger RNA transport and HIV rev regulation. , 1990, Science.

[48]  H. Olsen,et al.  Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. , 1990, Genes & development.

[49]  G. Pavlakis,et al.  Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein , 1990, Journal of virology.

[50]  M. Reitz,et al.  Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages , 1990, Journal of virology.

[51]  D. Baltimore,et al.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency , 1990, Cell.

[52]  E. Fenyö,et al.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 , 1990, Journal of virology.

[53]  G. Chinnadurai,et al.  Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. , 1990, Virology.

[54]  C. Rosen,et al.  Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function , 1990, Journal of virology.

[55]  A. Skalka,et al.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals , 1990, Molecular and cellular biology.

[56]  C. H. Chen,et al.  Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Cook,et al.  Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro , 1989, Nature.

[58]  Michael R. Green,et al.  Sequence-specific RNA binding by the HIV-1 Rev protein , 1989, Nature.

[59]  P. Sharp,et al.  Regulation by HIV Rev depends upon recognition of splice sites , 1989, Cell.

[60]  S. Le,et al.  Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Lazinski,et al.  Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif , 1989, Cell.

[62]  S. Ruben,et al.  Functional significance of phosphorylation to the human immunodeficiency virus Rev protein , 1989, Journal of virology.

[63]  D. Baltimore,et al.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression , 1989, Journal of virology.

[64]  N. Ahmad,et al.  Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Malim,et al.  Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function , 1989, Cell.

[66]  M. Emerman,et al.  The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization , 1989, Cell.

[67]  P. Legrain,et al.  Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm , 1989, Cell.

[68]  M. Hammarskjöld,et al.  Regulation of human immunodeficiency virus env expression by the rev gene product , 1989, Journal of virology.

[69]  S. Le,et al.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.

[70]  Michael R. Green,et al.  Revving up gene expression , 1989, Nature.

[71]  T. Copeland,et al.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  G. Pavlakis,et al.  The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region , 1989, Journal of virology.

[73]  M. Malim,et al.  Phosphorylation of the rev gene product of human immunodeficiency virus type 1 , 1988, Journal of virology.

[74]  D. Baltimore.  Intracellular immunization , 1988, Nature.

[75]  L. Montagnier,et al.  HIV/HTLV gene nomenclature , 1988, Nature.

[76]  Michael B. Mathews,et al.  Transcriptional but not translational regulation of HIV-1 by the tat gene product , 1988, Nature.

[77]  J. Sodroski,et al.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[78]  I. Herskowitz.  Functional inactivation of genes by dominant negative mutations , 1987, Nature.

[79]  J. Ghrayeb,et al.  Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis. , 1987, Science.

[80]  M. Feinberg,et al.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA , 1986, Cell.

[81]  J. Sodroski,et al.  A second post-transcriptional trans-activator gene required for HTLV-III replication , 1986, Nature.

[82]  J. Coligan,et al.  A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. , 1986, Science.

[83]  H. Varmus,et al.  Structure of viral DNA and RNA in mammalian cells infected with avian sarcoma virus. , 1980, Journal of molecular biology.

[84]  M. Green,et al.  Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. , 1991, Annual review of cell biology.

[85]  S. Ruben,et al.  Structural and functional characterization of the human immunodeficiency virus rev protein. , 1989, Journal of acquired immune deficiency syndromes.